A naukri.com initiative
Bioengineer
1w
124
Image Credit: Bioengineer
2025 Transatlantic Exchange Program: Dana-Farber and Gustave Roussy Collaborate on Radioligand Therapy Research
- The Fourth Transatlantic Exchange in Oncology Conference is set to illuminate the vital intersection of radiopharmaceutical therapy and oncology
- The conference will not only serve as a platform for the exchange of cutting-edge scientific insights but will also cultivate collaborative ties aimed at driving progress in the field of oncology.
- Attendees can choose to participate in person at the Hyatt Regency Etoile Hotel or join the event via live stream, embracing the conference’s inclusive approach to dissemination of knowledge.
- Professor Toni Choueiri from Dana-Farber and Professor Karim Fizazi from Gustave Roussy will co-chair the event
- A core theme of the conference will center on the journey of non-radio-labeled targets transforming into radio-labeled products.
- The collaborative efforts between Dana-Farber and Gustave Roussy are underscored by a larger agreement that includes the alternating hosting of annual conferences between Boston and Paris.
- The spotlight on radioligand therapies during the conference reflects a wider recognition of their potential to revolutionize cancer treatment.
- As the conference date approaches, anticipation builds among oncologists, researchers, and educators alike.
- In the broader context, the discussions and findings shared during the conference will have ripple effects beyond the immediate community.
- The Fourth Transatlantic Exchange in Oncology Conference promises to be a convergence of ideas, insights, and innovations pivotal to the future of cancer treatment.
Read Full Article
7 Likes
For uninterrupted reading, download the app